浏览全部资源
扫码关注微信
1.中国中医科学院 中医临床基础医学研究所,北京 100700
2.中国中医科学院 西苑医院,北京 100091
Received:18 December 2021,
Published Online:01 June 2022,
Published:20 August 2022
移动端阅览
宋清雅,赵晓晓,刘光宇等.榄香烯乳状注射液真实世界疑似过敏反应的相关因素探讨[J].中国实验方剂学杂志,2022,28(16):109-115.
SONG Qingya,ZHAO Xiaoxiao,LIU Guangyu,et al.Factors Related to Real-world Suspected Allergic Reaction of Elememe Emulsion Injection[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(16):109-115.
宋清雅,赵晓晓,刘光宇等.榄香烯乳状注射液真实世界疑似过敏反应的相关因素探讨[J].中国实验方剂学杂志,2022,28(16):109-115. DOI: 10.13422/j.cnki.syfjx.20221693.
SONG Qingya,ZHAO Xiaoxiao,LIU Guangyu,et al.Factors Related to Real-world Suspected Allergic Reaction of Elememe Emulsion Injection[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(16):109-115. DOI: 10.13422/j.cnki.syfjx.20221693.
目的
2
基于医院信息系统分析榄香烯乳状注射液引发疑似过敏反应的因素。
方法
2
从全国60家三甲医院信息系统中收集使用过榄香烯乳状注射液的病例,采用巢式病例对照设计法,按疑似过敏组与对照组人数1∶4的比例匹配,应用SAS 9.3对患者的性别、年龄、职业、入院途径、入院病情、诊断信息等进行频次及百分比的描述性分析。采用传统logistic回归及倾向性评分加权logistic回归方法对疑似过敏发生的影响因素进行分析,自变量数量大于样本量者采用最小最大凹惩罚项(MCP)方法筛选关键变量,比较两组患者的入院病情、住院病情、住院天数、诊断信息、用药信息等方面的差异。
结果
2
疑似过敏组及对照组患者男女比例均约为2∶1,年龄分段均以46~65岁居多,对照组职业以“专业技术人员”为主,疑似过敏组职业以“商业、服务业人员”和“办事人员和有关人员”为主,入院方式均以门诊收入为主,入院病情均主要为一般。与对照组比较,疑似过敏组患者住院期间病情较重,平均住院天数较短,静脉滴注的给药方式所占比重较高,治愈率及有效率较低。logistic回归分析结果显示,疑似过敏组与对照组的入院病情、住院天数、合并疾病、用药剂量及疗程等差异均无统计学意义。
结论
2
榄香烯乳状注射液疑似过敏反应的发生多出现于首次用药过程中,呈速发型,低于常用剂量即可发生,与静脉滴注的给药方式、住院期间病情较重存在相关性。与患者的入院病情、住院天数、疗程、合并用药信息、诊断信息等无明显关联。由此可推测榄香烯乳状注射液疑似过敏反应可能与患者的过敏体质、免疫状态相关。
Objective
2
To analyze factors related to the suspected allergic reaction of elememe emulsion injection based on hospital information system.
Method
2
Data on cases that used elememe emulsion injection were collected from the information systems of 60 first-class hospitals nationwide. The nested case-control design method was adopted. Finally, 30 cases were included in the suspected allergy group and 120 cases in the control group. SAS 9.3 was employed for descriptive analysis of the gender, age, occupation, admission route, conditions of patients at the admission, and the diagnosis with frequency and percentage. The factors affecting the occurrence of suspected allergic reaction were analyzed by conventional logistic regression and propensity score weighted logistic regression. In the case that the number of independent variables was larger than the sample number, MCP (minimax concave penalty) was used to screen the key variables and the conditions of patients at admission, conditions of patients during hospitalization, hospital stay, diagnostic information, and medication information were compared between two groups.
Result
2
The male-to-female ratio was about 2∶1 in both groups and most of the patients were 46-65 years old. Patients in the control group were mainly "professional and technical personnel", and the majority in the suspected allergy group were "business and service personnel" and "clerks and related personnel". They were mainly admitted at the outpatient and conditions of patients were average at the admission. Compared with the control group, suspected allergy group showed severe conditions during the hospitalization, short average hospital stay, large proportion with intravenous infusion, and low cure rate and effective rate. The results of logistic regression analysis showed no statistical difference in conditions of patients at admission, hospital stay, combined diseases, medicine dosage, and treatment course.
Conclusion
2
The suspected allergic reaction of elememe emulsion injection mainly occurs in the first administration with rapid onset even with the dose lower than the commonly used one. The occurrence is related to the intravenous infusion and the severe conditions of patients during hospitalization and has nothing to do with the conditions of patients at admission, hospital stay, treatment course, use of other medicines, and diagnostic information. In summary, it is mainly related to the constitution and immune status of patients.
SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .
张伯臾 . 中医内科学 [M]. 上海 : 上海科学技术出版社 , 1985 : 189 - 190 .
陈伟霞 , 牛垚飞 , 康研 , 等 . 抗肿瘤中成药注射剂研究现状 [J]. 中国老年学杂志 , 2021 , 41 ( 23 ): 5439 - 5442 .
张明 , 杜东杰 , 石金苓 , 等 . β -榄香烯对结肠癌SW480细胞放疗增敏作用 [J]. 中国临床药理学杂志 , 2018 , 34 ( 23 ): 2719 - 2722 .
杨梅 , 谭越 , 李纲 , 等 . 榄香烯乳注射液联合全颅放疗治疗乳腺癌脑转移的近期疗效观察 [J]. 中国医药指南 , 2018 , 16 ( 20 ): 9 - 10 .
陈心蕊 , 周宋汇 , 汪瑞辰 , 等 . β -榄香烯抗DDP耐药卵巢癌细胞SKOV3/DDP作用及机制研究 [J]. 药学与临床研究 , 2021 , 29 ( 2 ): 81 - 85 .
郭宪伟 . 静脉注射榄香烯乳对围手术期胃癌患者细胞免疫功能的影响 [D]. 福州 : 福建中医药大学 , 2010 .
王乔宇 , 赵志刚 . 榄香烯抗肿瘤作用机制研究进展 [J]. 药学进展 , 2020 , 44 ( 7 ): 546 - 551 .
姚睿嫔 , 俞超芹 , 张丹英 , 等 . 榄香烯乳单药腔内注射缓解难治性卵巢癌恶性胸腹水(附12例) [J]. 现代肿瘤医学 , 2017 , 25 ( 14 ): 2288 - 2290 .
张改英 , 崔发平 , 刘永兰 , 等 . 榄香烯注射液不良反应及其防治 [J]. 世界最新医学信息文摘 , 2019 , 19 ( 53 ): 206 - 207 .
吴相呈 , 黄金华 , 周伟生 . 榄香烯乳的抑瘤作用及其不良反应的防治 [J]. 中药新药与临床药理 , 2004 , 15 ( 1 ): 70 - 72 .
高文斌 , 唐玉新 . 榄香烯乳剂的几种少见不良反应及其临床防治 [J]. 罕少疾病杂志 , 2000 , 7 ( 1 ): 42 .
夏爱金 , 梁丽容 , 朱俊 , 等 . 56例榄香烯注射液不良反应文献分析 [J]. 海峡药学 , 2017 , 29 ( 10 ): 277 - 278 .
王安铸 , 王志飞 , 谢雁鸣 , 等 . 基于巢氏病例对照研究的醒脑静注射液疑似过敏反应影响因素分析 [J]. 世界科学技术—中医药现代化 , 2021 , 23 ( 3 ): 693 - 698 .
孙红卫 , 杨文越 , 王慧 , 等 . 惩罚logistic回归用于高维变量选择的模拟评价 [J]. 中国卫生统计 , 2016 , 33 ( 4 ): 607 - 611 .
高文斌 , 吕明 . 榄香烯乳剂致不良反应3例报道 [J]. 罕少疾病杂志 , 2000 ( 2 ): 65 .
郭鹏 , 朱为康 , 李雁 , 等 . 榄香烯乳剂治疗中晚期肝癌的疗效与安全性的临床观察 [J]. 世界中医药 , 2018 , 13 ( 3 ): 676 - 678,682 .
张彪 , 白宇 , 顾晓群 . 肿瘤相关性血栓疾病的风险评估与治疗 [J]. 实用老年医学 , 2018 , 32 ( 4 ): 306 - 311 .
MARTINEZ C , SUISSA S , RIETBROCK S , et al . Testosterone treatment and risk of venous thromboembolism:population based case-control study [J]. BMJ , 2016 , 355 : i5968 .
LYMAN G H , BOHLKE K , KHORANA A A , et al . Venous thromboembolism prophylaxis and treatment in patients with cancer:American society of clinical oncology clinical practice guideline update 2014 [J]. J Clin Oncol , 2015 , 33 ( 6 ): 654 - 656 .
董莹 . 榄香烯乳注射液对化疗引起的易栓状态(血瘀证)的干预作用研究 [D]. 北京 : 北京中医药大学 , 2011 .
李书有 . 榄香烯乳剂、NP方案、沙利度胺综合治疗对晚期非小细胞肺癌凝血功能的影响 [J]. 现代中西医结合杂志 , 2017 , 26 ( 15 ): 1673 - 1676 .
张雷 , 聂春兰 , 侯莹 , 等 . 胸腺肽对恶性肿瘤患者外周血免疫细胞功能的影响 [J]. 中外医学研究 , 2015 , 13 ( 34 ): 20 - 21 .
辛海荣 , 宋宇豹 , 仲杨 , 等 . 胸腺肽 α 1对普外科肿瘤合并感染患者免疫功能和炎症细胞因子的影响 [J]. 山西医药杂志 , 2018 , 47 ( 22 ): 2688 - 2690 .
严米云 , 胡家保 . 奥沙利铂联合胸腺肽治疗肺癌合并恶性胸腔积液的临床效果与安全性 [J]. 临床合理用药杂志 , 2021 , 14 ( 16 ): 80 - 82 .
黎军辉 , 刘明盛 . 注射用重组人白介素联合替考拉宁对肺癌伴肺部感染患者的临床疗效 [J]. 基层医学论坛 , 2018 , 22 ( 28 ): 3994 - 3995 .
0
Views
27
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution